Pitfalls of toxicological analysis

Legal Medicine

Volumn 5, Issue SUPPL. 1, 2003, Pages S6-

  Schütz, Harald ^a   Erdmann, Freidoon ^a   Verhoff, Marcel A ^a   Weiler, Günter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adulterations; Gas chromatography mass spectrometry; High performance liquid chromatography; Immunoassays; Interpretation; Manipulations; Pharmacodynamic; Pharmacokinetics; Pitfalls; Toxicological analysis

Indexed keywords

AMBROXOL; AMPHETAMINE; BUFLOMEDIL; CARBAMAZEPINE; CIPROFLOXACIN; CLOZAPINE; CYCLOHEXYLAMINE; DIPHENHYDRAMINE; DISOPYRAMIDE; GEMFIBROZIL; MEBEVERINE; METRONIDAZOLE; NEFOPAM; NITROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETHIDINE; PHENETHYLAMINE; PSYCHOTROPIC AGENT; RIFAMPICIN; RITODRINE; SALICYLIC ACID DERIVATIVE; SELEGILINE; SERTRALINE; SIBUTRAMINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

ANALYTIC METHOD; ANALYTICAL ERROR; ANALYTICAL PARAMETERS; CALIBRATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG CROSS REACTIVITY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INDUCTION; EXTRELUT; FORENSIC SCIENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTOXICATION; LABORATORY TEST; PH; PHARMACODYNAMICS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TEMPERATURE; THIN LAYER CHROMATOGRAPHY; TOXICOKINETICS; TOXICOLOGY;

EID: 17444447284     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1344-6223(02)00084-6     Document Type: Conference Paper

References (84)

1. Specht W, Katte W Giftverdacht?: Darstellung für die Praxis der Polizei- und Zollbeamten, für Juristen und Amtsärzte. Hamburg: Kriminalistik-Verlag, 1954 (modified by Weyrich G and Schütz H).
2. Raaijmakers C. (personal communication).
3. Macallum and Benson 1909 (in [2]).
4. Gounden D, Newall RG. Urine specific gravity measurements: Comparison of a new reagent strip method with existing methodologies, as applied to the water concentration/dilution test. Curr Med Res Opin 1983;8:375-381.
5. Lafolie P, Beck O, Blennow G, Boreus L, Elwin CE, Karsson L, Odelius G, Hjemdahl P. Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem 1991;37:1927-1931.
6. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem 1988;34:2333-2336.
7. Pearson SD, Ash KO, Urry FM. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine™ eyedrops. Clin Chem 1989;35:636-638.
8. Warner A. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem 1989;35:638-651.
9. Bronner W, Nymann P, Von Minden D. Detectability of phencyclidine and 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in adulterated urine by radioimmunoassay and fluorescence polarization immunoassay. J Anal Toxicol 1990;14:368-371.
10. Cody JT. Specimen adulteration in drug urinalysis. Forensic Sci Rev 1990;2:63-75.
11. Hagemann P, Siegrist M. Verfälschungsstoffe beim Drogennachweis. Lab Med 1990;14:114-120.
12. Needleman SB, Porvaznik M, Ander D. Creatinine analysis in single collection urine specimens. J Forensic Sci 1992;37:1125-1133.
13. Edwards C. Fyfe MJ, Liu RH, Walia AS. Evaluation of common urine specimen adulteration indicators. J Anal Toxicol 1993;17:251-252.
14. Sansom HL, Freser MD, Botelho C, Kuntz DC, Foltz RL. Detection of urine specimens adulterated with Urine Aid. Presented at the Society of Forensic Toxicologists Annual Meeting. Phoenix (AZ), 1993.
15. Schwarzhoff R, Cody JT. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. J Anal Toxicol 1993;17:14-17.
16. Baiker C, Serrano L, Lindner B. Hypochlorite adulteration of urine causing decreased concentration of delta-9-THC-COOH by GC/MS. J Anal Toxicol 1994;18:101-103.
17. Goldberger BA, Caplan YH. Effect of glutaraldehyde (Urine Aid) on detection of abused drugs in urine by immunoassay. Clin Chem 1994;40:1605-1606.
18. Wu A, Schmalz J, Bennett W. Identification of Urine Aid adulterated specimens by fluorimetric analysis. Clin Chem 1994;40:845-846.
19. Cody JT. Adulteration of urine specimens. In: Liu RH, Goldberger BA, editors. Handbook of Workplace Drug Testing, Washington, DC: AACC Press, 1995. pp. 181-208.
20. George S, Braithwaite RA. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening. Addiction 1995;90:967-970.
21. Goldberger BA, Loewenthal B, Darwin WD, Cone EJ. Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of heroin users. Clin Chem 1995;41:116-117.
22. Notarriani LJ, Belk D, Collins AJ. False positives and negatives in routine testing for drugs of abuse. Lancet 1995;345:1115.
23. Wu AHB, Forte E, Casella G, Sun K, Hemphill G, Forey R, Schanzenbach H. Cedia for screening drugs of abuse in urine adulterants. J Forensic Sci 1995;40:614-618.
24. George S, Braithwaite RA. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs-of-abuse assays. J Anal Toxicol 1996;20:195-196.
25. Poklis A, O'Neal C. Potential for false-positive results by the TRIAGE™ panel of drugs-of-abuse immunoassay. J Anal Toxicol 1996;20:209-210.
26. ElSohly MA, Feng S, Kopycki WJ, Murphy TP, Jones AB, Davis A, Carr D. A procedure to overcome interferences caused by adulterant 'Klear' in the GC/MS analysis of 11-nor-delta-9-THC-9-COOH. J Anal Toxicol 1997;21:240-242.
27. Martz W. Untersuchungen zu propagierten Methoden der Urinverfälschung vor dem Drogentest. Toxichem + Krimtech 1997;64:88-94.
28. Smith BL, Wilson FW. Effect of adulterants on urine tests. Ther Drug Monit 1997;5:586.
29. Skopp G, Pötsch L, Becker J, Röhrich J, Mattern R. Zur präanalytischen Phase chemisch-toxikologischer Untersuchungen. Rechtsmedizin 1998;8:163-167.
30. Tsai SC, ElSohly MA, Dubrovsky T, Twarowska B, Towt J, Salamone SJ. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry. J Anal Toxicol 1998;22:474-480.
31. Urry FM, Komaromy-Hiller G, Staley B, Crockett DK, Kushnir M, Nelson G, Struempler RE. Nitrite adulteration of workplace urine drug-testing speciments. J Anal Toxicol 1998;22:89-95.
32. Davis KH. Adulterants update. Society of Forensic Toxicologists Annual Meeting. San Juan (Puerto Rico), 1999.
33. Singh J, Elberling JS, Hemphill DG, Holmstrom J. The measurement of nitrite in adulterated urine samples by high-performance ion chromatography. J Anal Toxicol 1999;23:137-140.
34. Wu AH, Bristol B, Sexton K, Cassella-McLane G, Holtman V, Hill DW. Adulteration of urine by 'Urine Luck'. Clin Chem 1999;45:1051-1057.
35. Paul BD, Martin KK, Maguilo Jr J, Smith ML. Effects of pyridinium chlorochromate adulterant (urine luck) on testing for drugs of abuse and a method for quantitative detection of chromium (VI) in urine. J Anal Toxicol 2000;24:233-237.
36. Tytgat J, Van Boven M, Daenens P. Cannabinoid mimics in chocolate utilized as an argument in court. Int J Legal Med 2000;113:137-139.
37. Cody JT, Valtier S. Effects of stealth adulterant on immunoassay testing for drugs of abuse. J Anal Toxicol 2001;25:466-470.
38. Cody JT, Valtier S, Kuhlman J. Analysis of morphine and codeine in samples adulterated with stealth™. J Anal Toxicol 2001;25:572-575.
39. Schütz H. Benzodiazepines. A Handbook. Berlin: Springer, 1989.
40. Liu RH. Important considerations in the interpretation of forensic drug test results. Forensic Sci Rev 1992;4:52-65.
41. Schütz H. Screening von Drogen und Arzneimitteln mit Immunoassays. Ein Leitfaden für die Praxis. 1999.
42. Schütz H, Rochholz G, Weiler G. Zur Problematik der falsch negativen Benzodiazepin-Immunoassays. Klin Lab 1992;38:150-152.
43. Schütz H, Rochholz G, Weiler G. Trügerische Spuren. Kriminalistische und forensische Aspekte falsch negativer Benzodiazepin-Immunoassays in Urinproben. Kriminalistik 1992;46:333-335.
44. Liu RH. Comparison of common immunoassay kits for effective application in workplace drug urinalysis. Forensic Sci Rev 1994;6:19-57.
45. Luceri F, Godi F, Messeri G. Reducing false-negative tests in urinary drugs-of-abuse screening. J Anal Toxicol 1997;21:244-245.
46. Schütz H, Erdmann F, Rochholz G, Weiler G. False positive and false negative immunochemical findings: A permanent risk of analytical pitfalls. Jpn J Forensic Toxicol 2000;18:14-20.
47. Lotz J, Hafner G, Röhrich J, Zörntlein S, Kern T, Prellwitz W. False positive LSD drug screening induced by a mucolytic medication. Clin Chem 1998;44:1580-1581.
48. Röhrich J, Zörntlein S, Lotz J, Becker J, Rittner C. False-positive LSD testing in urine samples from intensive care patients. J Anal Toxicol 1998;22:393-395.
49. Schütz H, Erdmann F, Magiera ES, Weiler G. Fehlerhafte Bestätigungsanalytik bei falsch-positiven Immunoassays und ihre Auswirkungen. Arch Krim 1998;35:93-96.
50. Mura P, Kintz P, Robert R, Papet Y. Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. J Anal Toxicol 1998;22:254.
51. Lora-Tamayo C, Tena T, Rodriguez A. High concentration of ciprofloxacin in urine invalidates EMIT results. J Anal Toxicol 1996;20:334.
52. Schneider S, Wennig R. Interference of diphenhydramine with the EMIT II immunoassay for propoxyphene. J Anal Toxicol 1999;23:637-638.
53. Moorman P, McCoy M, Hague B, Huge D. Disopyramide cross-reactivity in a commercial immunoassay for methadone. J Anal Toxicol 1999;23:299-300.
54. Lewis JH. Interference of gemfibrozil with Roche Testcup. J Anal Toxicol 1999;23:384.
55. Brunk SD. False negative GC/MS assay for carboxy THC due to ibuprofen interference. Clin Chem 1988;12:290-291.
56. Krämer, T., Bock, K., Wennig, R., Maurer, H.H., The antispasmodic mebeverine leads to positive amphetamine results with the fluorescence polarization immuno assay. Studies on the metabolism and the toxicological detection in urine by GC/MS and FPIA. Mosbach: XI Symposium der GTFCh, 1999. pp. 34-43.
57. Krämer T, Wennig R, Maurer HH. The antispasmodic mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA). Studies on the toxicological analysis of urine by FPIA and GC-MS. J Anal Toxicol 2001;25:333-338.
58. Lora-Tamayo C, Tena T. High concentrations of metronidazole in urine invalidates EMIT results. J Anal Toxicol 1991;15:159.
59. Al-Amri AM, El-Haj BM. Positive interference of the analgesic drug nefopam in the enzyme immunoassay (EMIT D.A.U.) for benzodiazepines. Bull Int Assoc Forensic Toxicol 1999;29:4.
60. Larsen J, Fogerson R. Nonsteroidal anti-inflammatory drug interferences in TDx assays for abused drugs. Clin Chem 1988;34:987-988.
61. Rollins DE, Jennison TA, Jones G. Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs. Clin Chem 1990;36:602-606.
62. Meatherall R, Dai J. False-positive EMIT II opiates from ofloxacin. Ther Drug Monit 1997;19:98-99.
63. Schudie;tz H, Erdmann F, Weiler G. Folgen unbestätigter Immunoassays mit miβverständlichem Befundbericht. Toxichem + Krimtech 1997;64:95.
64. Matuch-Hite T, Jones Jr P, Moriarity J. Interference of oxaprozine with benzodiazepines via enzyme immunoassay technique. J Anal Toxicol 1995;19:130.
65. Nishikawa T, Kamijo Y, Ohtani H, Fraser AD. Oxaprozin interference with urinary benzodiazepine immunoassay and noninterference with receptor assay. J Anal Toxicol 1999;23:125-126.
66. Marson C, Schneider S, Meys F, Wennig R. Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results. J Anal Toxicol 2000;24:17-21.
67. Van As H, Stolk LM. Rifampicin cross-reacts with opiate immunoassay. J Anal Toxicol 1999;23:71.
68. Podkowik BI, Repka ML, Smith ML. Interference by ritodrine in GC/MS confirmation of delta-9-tetrahydrocannabinol-9-carboxylic acid in urine. Clin Chem 1991;37:1305-1306.
69. Linder MW, Valdes R. Mechanism and elimination of aspirin induced interferences in EMIT II d.a.u. assays. Clin Chem 1994;40:1512-1516.
70. Wagener RE, Linder MW, Valdes R. Decreased signal in EMIT assays of drug abuse in urine after ingestion of aspirin: Potential of false-negative results. Clin Chem 1994;40:608-612.
71. Bogusz M, Maier RD, Hoenen H. Positive LSD immunoassay after sertraline intake. Bull Int Assoc Forensic Toxicol 1998;28:11-12.
72. Schütz H, Schneider WR, Schölermann K. Verbessertes enzym-immunologisches Screeningverfahrenfür Benzodiazepine im Harn nach EXTRELUT®-Anreicherung. Ärztl Lab 1988;34:130-136.
73. Meyer VR. Pitfalls and Errors of HPLC in Pictures. Heidelberg: Hüthig, 1997.
74. Vecchi M, Englert G, Maurer R, Meduna V. Trennung und Charakterisierung von β-Carotin-Isomeren. Helv Chim Acta 1981;64:2746-2758.
75. Welinder BS, Sørensen HH, Hejnæs KR, Linde S, Hansen B. HPLC of Proteins, Peptides and Polynucleotides. New York, NY: VCH, 1991 p. 495-553.
76. Lukulay PH, McGuffin VL. Experimental and computer simulation studies of solute-solute interactions in liquid chromatography. J Liq Chromatogr Relat Technol 1996;19:2039-2058.
77. Kirschbaum J, Noroski J, Cosey A, Mayo D, Adamovics J: High-performance liquid chromatography of the drug fosenopril. J Chromatogr 1990;507:165.
78. Besserer K. Ein Giftmord mit Nitrosodimethylamin. Mosbach: GTFCh-Symposium, 1997. pp. 41-148.
79. Pedal I, Besserer K, Goerttler K, Heymer B, Mittmeyer H-J, Oehmichen M, Schmähl D. Fatal nitrosamine poisoning. Arch Toxicol 1982;50:101-112.
80. Schulz H-J. Nitrofen-Bestimmung mit GC/MSD-NCI. Agilent Technologies Publ. No. 5988-7328DEE.
81. Koch HP, Ritschel WA. Synopsis der Biopharmazie und Pharmakokinetik. Landsberg, München: Ecomed Verlagsgesellschaft, 1986.
82. Aebi B, Bernhard W. Advances in the use of mass spectral libraries for forensic toxicology. J Anal Toxicol 2002;26:149-156.
83. Schütz H. Screening von Drogen und Arzneimitteln mit Immunoassays. Wiesbaden: Wiss. Verlagsabteilung Abbott GmbH, 1999.
84. Drasch G, V. Meyer L, Kauert G, Weger N. Ein Fall einer vaginalen Cyanid-Beibringung. Arch Kriminol 1982;170:21-28.